Method Of In Vitro T-Cell Diffeerentiation Of CD34 Progenitor Cells Read more about Method Of In Vitro T-Cell Diffeerentiation Of CD34 Progenitor Cells US Application 60/162,574Filed on 1999-10-29
Recovery of Recombinant Human Metapneumovirus (HPMV) From CDNA and Use of Recombinant HMPV in Immunogenic Compositions and As Vectors to Elicit Immune Responses Against HMPV and Other Human Pathogens Read more about Recovery of Recombinant Human Metapneumovirus (HPMV) From CDNA and Use of Recombinant HMPV in Immunogenic Compositions and As Vectors to Elicit Immune Responses Against HMPV and Other Human Pathogens US Application 60/451,119Filed on 2003-02-28
Paramyxoviruses As Gene Transfer Vectors To Lung Cells Read more about Paramyxoviruses As Gene Transfer Vectors To Lung Cells US Application 60/326,535Filed on 2001-09-28
P. Ariasi Polypeptides And P. Perniciosus Polypeptides Methods Of Use Read more about P. Ariasi Polypeptides And P. Perniciosus Polypeptides Methods Of Use US Application 60/425,852Filed on 2002-11-12
Identification of Chimpanzee FAB Fragments by Repertoire Cloning and Production of a Full-Length Humanized IgG1 Antibody Highly Efficient Neutralization of Dengue Type 4 Virus Read more about Identification of Chimpanzee FAB Fragments by Repertoire Cloning and Production of a Full-Length Humanized IgG1 Antibody Highly Efficient Neutralization of Dengue Type 4 Virus US Application 60/528,161Filed on 2003-12-08
Dengue Tetravalent Vaccine Containing a Common 30 Nucleotide Deletion in The 3'-UTR of Dengue Types 1,2,3, And 4 Read more about Dengue Tetravalent Vaccine Containing a Common 30 Nucleotide Deletion in The 3'-UTR of Dengue Types 1,2,3, And 4 US Application 60/436,500Filed on 2002-12-23
Safer Attentuated Virus Vaccines with Missing or Diminished Latency of Infection Read more about Safer Attentuated Virus Vaccines with Missing or Diminished Latency of Infection US Application 60/423,603Filed on 2002-11-05
HTLV-1-Cell Binding & Inhibition Read more about HTLV-1-Cell Binding & Inhibition US Application 60/422,803Filed on 2002-10-30
Recovery of Recombinant Human Parainfluenza Virus Type 2 (HPIV2) From cDNA and Use of Recombinant HPIV2 in Immunogenic Compositions and as Vectors to Elicit Immune Responses Against PIV and Other Human Pathogens. Read more about Recovery of Recombinant Human Parainfluenza Virus Type 2 (HPIV2) From cDNA and Use of Recombinant HPIV2 in Immunogenic Compositions and as Vectors to Elicit Immune Responses Against PIV and Other Human Pathogens. US Application 60/412,053Filed on 2002-09-18
Non-Viral Mammalian Expression Vector Read more about Non-Viral Mammalian Expression Vector US Application 60/413,117Filed on 2002-09-24